[Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of The Finnish Diabetes Organization].
Owing to advances in the diagnosis and treatment of diabetic nephropathy, its management has become more active and is now initiated earlier after the presence of microalbuminuria has been established. In 1996 the Finnish Diabetic Association's nephropathy group issued recommendations concerning screening for diabetic nephropathy, and treatment and follow-up of patients with the disease.
Koivisto
V
V
Medicinska kliniken, Helsingfors Universitetscentralsjukhus.
Groop
P H
PH
Huttunen
N P
NP
Kivekäs
J
J
Pasternack
A
A
Uusitupa
M
M
Viikari
J
J
D000293:Adolescent; D000419:Albuminuria / Q000652:urine; D002648:Child; D017281:Cost of Illness; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000191:economics / Q000503:physiopathology / Q000628:therapy*; D004044:Dietary Proteins; D005260:Female; D005387:Finland; D006801:Humans; D006943:Hyperglycemia / Q000628:therapy; D006977:Hypertension, Renal / Q000628:therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications; D011247:Pregnancy; D014511:Uremia / Q000628:therapy
D004044:Dietary Proteins; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents